Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Jan 1;97(1):250–257. doi: 10.1172/JCI118399

The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2.

Y Weinrauch 1, P Elsbach 1, L M Madsen 1, A Foreman 1, J Weiss 1
PMCID: PMC507087  PMID: 8550843

Abstract

The cell-free fluid (ascitic fluid, AF) of a sterile inflammatory peritoneal exudate elicited in rabbits is potently bactericidal for complement-resistant gram-negative as well as gram-positive bacterial species. This activity is absent in plasma. We now show that essentially all activity in AF against Staphylococcus aureus is attributable to a group II 14-kD phospholipase A2 (PLA2), previously purified from AF in this laboratory. Antistaphylococcal activity of purified PLA2 and of whole AF containing a corresponding amount of PLA2 was comparable and blocked by anti-AF-PLA2 serum. At concentrations present in AF (approximately 10 nM), AF PLA2 kills > 2 logs of 10(6) S. aureus/ml, including methicillin-resistant clinical isolates, and other species of gram-positive bacteria. Human group II PLA2 displays similar bactericidal activity toward S. aureus (LD90 approximately 1-5 nM), whereas 14-kD PLA2 from pig pancreas and snake venom are inactive even at micromolar doses. Bacterial killing by PLA2 requires Ca2+ and catalytic activity and is accompanied by bacterial phospholipolysis and disruption of the bacterial cell membrane and cell wall. These findings reveal that group II extracellular PLA2, the function of which at inflammatory sites has been unclear, is an extraordinarily potent endogenous antibiotic against S. aureus and other gram-positive bacteria.

Full Text

The Full Text of this article is available as a PDF (219.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archer G. L., Niemeyer D. M. Origin and evolution of DNA associated with resistance to methicillin in staphylococci. Trends Microbiol. 1994 Oct;2(10):343–347. doi: 10.1016/0966-842x(94)90608-4. [DOI] [PubMed] [Google Scholar]
  2. BLIGH E. G., DYER W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959 Aug;37(8):911–917. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
  3. Carroll S. F., Martinez R. J. Antibacterial peptide from normal rat serum. 1. Isolation from whole serum, activity, and microbicidal spectrum. Biochemistry. 1981 Oct 13;20(21):5973–5981. doi: 10.1021/bi00524a008. [DOI] [PubMed] [Google Scholar]
  4. Cohen M. L. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science. 1992 Aug 21;257(5073):1050–1055. doi: 10.1126/science.257.5073.1050. [DOI] [PubMed] [Google Scholar]
  5. Crowl R. M., Stoller T. J., Conroy R. R., Stoner C. R. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem. 1991 Feb 5;266(4):2647–2651. [PubMed] [Google Scholar]
  6. Dennis E. A. Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem. 1994 May 6;269(18):13057–13060. [PubMed] [Google Scholar]
  7. Donaldson D. M., Tew J. G. beta-Lysin of platelet origin. Bacteriol Rev. 1977 Jun;41(2):501–513. doi: 10.1128/br.41.2.501-513.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Elsbach P., Weiss J., Kao L. The role of intramembrane Ca2+ in the hydrolysis of the phospholipids of Escherichia coli by Ca2+-dependent phospholipases. J Biol Chem. 1985 Feb 10;260(3):1618–1622. [PubMed] [Google Scholar]
  9. Elsbach P., Weiss J., Levy O. Integration of antimicrobial host defenses: role of the bactericidal/permeability-increasing protein. Trends Microbiol. 1994 Sep;2(9):324–328. doi: 10.1016/0966-842x(94)90449-9. [DOI] [PubMed] [Google Scholar]
  10. Elsbach P., Weiss J. Phagocytosis of bacteria and phospholipid degradation. Biochim Biophys Acta. 1988 Feb 24;947(1):29–52. doi: 10.1016/0304-4157(88)90018-4. [DOI] [PubMed] [Google Scholar]
  11. Elsbach P., Weiss J. Utilization of labeled Escherichia coli as phospholipase substrate. Methods Enzymol. 1991;197:24–31. doi: 10.1016/0076-6879(91)97130-q. [DOI] [PubMed] [Google Scholar]
  12. Fischer W. Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus. Med Microbiol Immunol. 1994 May;183(2):61–76. doi: 10.1007/BF00277157. [DOI] [PubMed] [Google Scholar]
  13. Forst S., Weiss J., Blackburn P., Frangione B., Goni F., Elsbach P. Amino acid sequence of a basic Agkistrodon halys blomhoffii phospholipase A2. Possible role of NH2-terminal lysines in action on phospholipids of Escherichia coli. Biochemistry. 1986 Jul 29;25(15):4309–4314. doi: 10.1021/bi00363a020. [DOI] [PubMed] [Google Scholar]
  14. Forst S., Weiss J., Elsbach P., Maraganore J. M., Reardon I., Heinrikson R. L. Structural and functional properties of a phospholipase A2 purified from an inflammatory exudate. Biochemistry. 1986 Dec 30;25(26):8381–8385. doi: 10.1021/bi00374a008. [DOI] [PubMed] [Google Scholar]
  15. Forst S., Weiss J., Maraganore J. M., Heinrikson R. L., Elsbach P. Relation between binding and the action of phospholipases A2 on Escherichia coli exposed to the bactericidal/permeability-increasing protein of neutrophils. Biochim Biophys Acta. 1987 Aug 15;920(3):221–225. doi: 10.1016/0005-2760(87)90098-1. [DOI] [PubMed] [Google Scholar]
  16. Gabay J. E. Ubiquitous natural antibiotics. Science. 1994 Apr 15;264(5157):373–374. doi: 10.1126/science.8153623. [DOI] [PubMed] [Google Scholar]
  17. HIRSCH J. G. Phagocytin: a bactericidal substance from polymorphonuclear leucocytes. J Exp Med. 1956 May 1;103(5):589–611. doi: 10.1084/jem.103.5.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hanasaki K., Arita H. Characterization of a high affinity binding site for pancreatic-type phospholipase A2 in the rat. Its cellular and tissue distribution. J Biol Chem. 1992 Mar 25;267(9):6414–6420. [PubMed] [Google Scholar]
  19. Harwig S. S., Tan L., Qu X. D., Cho Y., Eisenhauer P. B., Lehrer R. I. Bactericidal properties of murine intestinal phospholipase A2. J Clin Invest. 1995 Feb;95(2):603–610. doi: 10.1172/JCI117704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Horigome K., Hayakawa M., Inoue K., Nojima S. Selective release of phospholipase A2 and lysophosphatidylserine-specific lysophospholipase from rat platelets. J Biochem. 1987 Jan;101(1):53–61. doi: 10.1093/oxfordjournals.jbchem.a121907. [DOI] [PubMed] [Google Scholar]
  21. Höltje J. V., Tomasz A. Lipoteichoic acid: a specific inhibitor of autolysin activity in Pneumococcus. Proc Natl Acad Sci U S A. 1975 May;72(5):1690–1694. doi: 10.1073/pnas.72.5.1690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Inada M., Crowl R. M., Bekkers A. C., Verheij H., Weiss J. Determinants of the inhibitory action of purified 14-kDa phospholipases A2 on cell-free prothrombinase complex. J Biol Chem. 1994 Oct 21;269(42):26338–26343. [PubMed] [Google Scholar]
  23. Jensen R. S., Tew J. G., Donaldson D. M. Extracellular beta-lysin and muramidase in body fluids and inflammatory exudates. Proc Soc Exp Biol Med. 1967 Feb;124(2):545–549. doi: 10.3181/00379727-124-31785. [DOI] [PubMed] [Google Scholar]
  24. Johnson F. B., Donaldson D. M. Purification of staphylocidal beta-lysin from rabbit serum. J Bacteriol. 1968 Sep;96(3):589–595. doi: 10.1128/jb.96.3.589-595.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kates M., Hancock A. J. Synthesis of monophytanyl ether analogues of lysophosphatidic and lysophosphatidyl glycerol. Chem Phys Lipids. 1976 Oct;17(2-3):155–168. doi: 10.1016/0009-3084(76)90059-1. [DOI] [PubMed] [Google Scholar]
  26. Kini R. M., Evans H. J. Structure-function relationships of phospholipases. The anticoagulant region of phospholipases A2. J Biol Chem. 1987 Oct 25;262(30):14402–14407. [PubMed] [Google Scholar]
  27. Kramer R. M., Pepinsky R. B. Assay and purification of phospholipase A2 from human synovial fluid in rheumatoid arthritis. Methods Enzymol. 1991;197:373–381. doi: 10.1016/0076-6879(91)97163-s. [DOI] [PubMed] [Google Scholar]
  28. Kudo I., Murakami M., Hara S., Inoue K. Mammalian non-pancreatic phospholipases A2. Biochim Biophys Acta. 1993 Nov 3;1170(3):217–231. doi: 10.1016/0005-2760(93)90003-r. [DOI] [PubMed] [Google Scholar]
  29. Lambeau G., Barhanin J., Lazdunski M. Identification of different receptor types for toxic phospholipases A2 in rabbit skeletal muscle. FEBS Lett. 1991 Nov 18;293(1-2):29–33. doi: 10.1016/0014-5793(91)81145-x. [DOI] [PubMed] [Google Scholar]
  30. Lambeau G., Schmid-Alliana A., Lazdunski M., Barhanin J. Identification and purification of a very high affinity binding protein for toxic phospholipases A2 in skeletal muscle. J Biol Chem. 1990 Jun 5;265(16):9526–9532. [PubMed] [Google Scholar]
  31. Mizushima H., Kudo I., Horigome K., Murakami M., Hayakawa M., Kim D. K., Kondo E., Tomita M., Inoue K. Purification of rabbit platelet secretory phospholipase A2 and its characteristics. J Biochem. 1989 Apr;105(4):520–525. doi: 10.1093/oxfordjournals.jbchem.a122699. [DOI] [PubMed] [Google Scholar]
  32. Murakami M., Kudo I., Inoue K. In vivo release and clearance of rat platelet phospholipase A2. Biochim Biophys Acta. 1989 Oct 17;1005(3):270–276. doi: 10.1016/0005-2760(89)90048-9. [DOI] [PubMed] [Google Scholar]
  33. Nevalainen T. J., Aho H. J., Peuravuori H. Secretion of group 2 phospholipase A2 by lacrimal glands. Invest Ophthalmol Vis Sci. 1994 Feb;35(2):417–421. [PubMed] [Google Scholar]
  34. Pruzanski W., Vadas P., Browning J. Secretory non-pancreatic group II phospholipase A2: role in physiologic and inflammatory processes. J Lipid Mediat. 1993 Nov;8(3):161–167. [PubMed] [Google Scholar]
  35. SKARNES R. C., WATSON D. W. Antimicrobial factors of normal tissues and fluids. Bacteriol Rev. 1957 Dec;21(4):273–294. doi: 10.1128/br.21.4.273-294.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Santos A. A., Browning J. L., Scheltinga M. R., Lynch E. A., Brown E. F., Lawton P., Chambers E., Dougas I., Benjamin C. D., Dinarello C. A. Are events after endotoxemia related to circulating phospholipase A2? Ann Surg. 1994 Feb;219(2):183–192. doi: 10.1097/00000658-199402000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Stoner C. R., Reik L. M., Donohue M., Levin W., Crowl R. M. Human group II phospholipase A2. Characterization of monoclonal antibodies and immunochemical quantitation of the protein in synovial fluid. J Immunol Methods. 1991 Dec 15;145(1-2):127–136. doi: 10.1016/0022-1759(91)90318-a. [DOI] [PubMed] [Google Scholar]
  38. Taylor P. W. Bactericidal and bacteriolytic activity of serum against gram-negative bacteria. Microbiol Rev. 1983 Mar;47(1):46–83. doi: 10.1128/mr.47.1.46-83.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Vadas P., Browning J., Edelson J., Pruzanski W. Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease states. J Lipid Mediat. 1993 Aug;8(1):1–30. [PubMed] [Google Scholar]
  40. Verheij H. M., Slotboom A. J., de Haas G. H. Structure and function of phospholipase A2. Rev Physiol Biochem Pharmacol. 1981;91:91–203. doi: 10.1007/3-540-10961-7_3. [DOI] [PubMed] [Google Scholar]
  41. Weinrauch Y., Foreman A., Shu C., Zarember K., Levy O., Elsbach P., Weiss J. Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate. J Clin Invest. 1995 Apr;95(4):1916–1924. doi: 10.1172/JCI117873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Weiss J., Beckerdite-Quagliata S., Elsbach P. Determinants of the action of phospholipases A on the envelope phospholipids of Escherichia coli. J Biol Chem. 1979 Nov 10;254(21):11010–11014. [PubMed] [Google Scholar]
  43. Weiss J., Inada M., Elsbach P., Crowl R. M. Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytes. J Biol Chem. 1994 Oct 21;269(42):26331–26337. [PubMed] [Google Scholar]
  44. Weiss J., Wright G., Bekkers A. C., van den Bergh C. J., Verheij H. M. Conversion of pig pancreas phospholipase A2 by protein engineering into enzyme active against Escherichia coli treated with the bactericidal/permeability-increasing protein. J Biol Chem. 1991 Mar 5;266(7):4162–4167. [PubMed] [Google Scholar]
  45. White D. C., Tucker A. N. Phospholipid metabolism during bacterial growth. J Lipid Res. 1969 Mar;10(2):220–233. [PubMed] [Google Scholar]
  46. Wright G. C., Weiss J., Kim K. S., Verheij H., Elsbach P. Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils. Role of cellular and extracellular phospholipases. J Clin Invest. 1990 Jun;85(6):1925–1935. doi: 10.1172/JCI114655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Wright G. W., Ooi C. E., Weiss J., Elsbach P. Purification of a cellular (granulocyte) and an extracellular (serum) phospholipase A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate. J Biol Chem. 1990 Apr 25;265(12):6675–6681. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES